Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Population-based cancer surveillance is a national treasure at risk
Guest Editorial

Population-based cancer surveillance is a national treasure at risk

September 26, 2025
Vol.51 No.35
By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash
Anthony G. Letai to be named NCI director
NCI

Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say

September 25, 2025
Vol.51 No.35
By Claire Marie Porter and Paul Goldberg
Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.
Podcast

Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.

September 24, 2025
Vol.51 No.34
NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium

NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium

September 19, 2025
Vol.51 No.34
By Paul Goldberg
NCI releases names of members of ad hoc working group—filling the void left by BSA
NCI

NCI releases names of members of ad hoc working group—filling the void left by BSA

September 19, 2025
Vol.51 No.34
By Sara Willa Ernst
In Brief

UCSF awarded $12M SPORE grant to study cancer outcomes for meningioma, prostate cancer, and breast cancer

September 19, 2025
Vol.51 No.34
In Brief

UTSW receives SPORE grant from NCI to study liver cancer

September 19, 2025
Vol.51 No.34
In Brief

Yale receives renewed lung cancer SPORE grant from NCI

September 19, 2025
Vol.51 No.34
NCORP recognizes Kathleen Yost Butler, Kamara Mertz-Rivera, Jordan Vogelsberg with 2025 awards
In Brief

NCORP recognizes Kathleen Yost Butler, Kamara Mertz-Rivera, Jordan Vogelsberg with 2025 awards

September 19, 2025
Vol.51 No.34
Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
Podcast

Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer

September 17, 2025
Vol.51 No.33

Posts navigation

Previous1…567…40Next

Trending Stories

  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives
  • The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
    Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish
  • The Galleri MCD vote: What FDA asked its advisors to ignore
  • FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
    Clinical benefit will not be considered for approval, FDA says
  • Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account